Lyell Immunopharma (LYEL) Shares Issued (2020 - 2026)
Lyell Immunopharma recorded quarterly Shares Issued of $26000.0 in Q1 2026, down 92.88% quarter-over-quarter from $365000.0 in Q4 2025.
Lyell Immunopharma's Shares Issued history runs 7 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- In Q1 2026, Shares Issued changed N/A year-over-year to $26000.0; the TTM figure through Mar 2026 stood at $391000.0 (up 479.61% YoY), while the FY2025 annual figure was $365000.0, changed N/A from the prior year.
- Shares Issued came in at $26000.0 for Q1 2026 at Lyell Immunopharma, down from $365000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $8.4 million in Q3 2022 to a low of -$7.7 million in Q4 2022.
- A 5-year average of $159166.7 and a median of $64500.0 in 2024 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued tumbled 278.51% in 2022 and surged 335.48% in 2025, its largest moves.
- Lyell Immunopharma's Shares Issued stood at -$7.7 million in 2022, then surged by 84.96% to -$1.2 million in 2023, then soared by 86.67% to -$155000.0 in 2024, then jumped by 335.48% to $365000.0 in 2025, then sank by 92.88% to $26000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $26000.0, $365000.0, and -$155000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Lyell Immunopharma | 373.31 Mn | 373.31 Mn | - | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 365,000.00 |
| Dec 31, 2025 | 365,000.00 |
| Dec 31, 2024 | -155,000.00 |
| Dec 31, 2024 | -155,000.00 |
| Sep 30, 2024 | -655,000.00 |
| Sep 30, 2024 | -655,000.00 |
| Jun 30, 2024 | 707,000.00 |
| Jun 30, 2024 | 707,000.00 |
| Mar 31, 2024 | 103,000.00 |
| Mar 31, 2024 | 103,000.00 |
| Dec 31, 2023 | -1.16 Mn |
| Dec 31, 2023 | -1.16 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Dec 31, 2022 | -7.73 Mn |
| Dec 31, 2022 | -7.73 Mn |
| Sep 30, 2022 | 8.37 Mn |
| Sep 30, 2022 | 8.37 Mn |
| Jun 30, 2022 | -1.67 Mn |
| Jun 30, 2022 | -1.67 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | -2.04 Mn |
| Dec 31, 2021 | -2.04 Mn |
| Sep 30, 2021 | -390.82 Mn |
| Sep 30, 2021 | -390.82 Mn |
| Jun 30, 2021 | 391.80 Mn |
| Jun 30, 2021 | 391.80 Mn |
| Mar 31, 2021 | 884,000.00 |
| Mar 31, 2021 | 884,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Dec 31, 2020 | -35,000.00 |
| Sep 30, 2020 | 35,000.00 |
| Sep 30, 2020 | 35,000.00 |